Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1216 (LINC01216) is a non-protein-coding RNA gene situated in an intergenic region of the genome, meaning it does not overlap with known protein-coding sequences. LINC01216 is a member of the lincRNA subfamily, which is distinguished by its position away from protein-coding genes and by unique epigenetic and transcriptional regulation. LincRNAs, including LINC01216, influence cellular function by remodeling chromatin, regulating transcription, modulating genome architecture, stabilizing RNA, or acting as enhancers for gene expression. Although thousands of lincRNAs have been annotated, only a minority have been studied in detail; the specific biological and disease roles of LINC01216 remain uncharacterized, with no reported evidence for its consideration as a clinical therapeutic target. LINC01216 is properly named and accurately described as a long intergenic non-protein coding RNA; it is not misclassified nor is there evidence for direct involvement in classical drug targeting or clinical biomarker use.
Not applicable; drugs targeting LINC01216 are not described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1216 (LINC01216).